Amfex M

A dual-action anti-allergic combination blocking both histamine (H1) and leukotriene pathways. (Philip G, 2004) Shown to reduce nasal symptoms by 72% in perennial allergic rhinitis versus 52% with monotherapy. (Patel P, 2007) The non-sedating fexofenadine component allows daytime use without impairment. (Simons FE, 2003)

Indication

• Allergic rhinitis (seasonal/perennial)
• Chronic urticaria
• Atopic dermatitis
• Mild asthma adjunct

Side Effects

• Fatigue
• Dyspepsia
• Rare eosinophilia